Merck has unveiled plans to invest €250 million in a new facility in Corsier-sur-Vevey, Switzerland. The new Merck Biotech Development Center will be dedicated to biotech development and manufacturing for clinical studies. Driven by the growth of the healthcare business sector R&D pipeline, the company says this investment will help to sustainably secure capacity and high agility to deliver clinical trial material in a cost-effective way, contribute to accelerated development timelines of ne...